ETV4 and sarcoma: High expression of ETV4 was remarkably correlated with poor disease-specific survival in GBMLGG, ACC, LGG, KIRC, GBM, LIHC, KIRP, MESO, and sarcoma, and with improved prognosis in thyroid carcinoma (THCA) (Figures 2D, 3D).